BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 28 found
  Current Search:  fentora: 28     

HTML
100%
Analysts see higher drug sales for Cephalon
NEW YORK - Sales of Cephalon Inc.'s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts said Friday.

Cephalon has somewhat shifted its focus to...

CNBC:  Jun 20 2008 5:02PM
Matching: fentora
Find similar documents
HTML
100%
Analysts expect increasing sales of Cephalon's muscle relaxant and cancer treatment
NEW YORK (AP) - Sales of Cephalon Inc.'s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts said Friday.

Cephalon has somewhat shifted its...

Canadian Business Magazine:  Jun 20 2008 4:36PM
Matching: fentora
Find similar documents
HTML
100%
Analysts see higher drug sales for Cephalon
Sales of Cephalon Inc.'s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts said Friday.

Cephalon has somewhat shifted its focus to Amrix and...

Forbes.com:  Jun 20 2008 4:31PM
Matching: fentora
Find similar documents
HTML
100%
Analysts see higher drug sales for Cephalon
Sales of Cephalon Inc.'s muscle relaxant Amrix and cancer treatment Treanda will likely continue to drive revenue for the Frazer, Pa.-based drug developer, several analysts said Friday.

Cephalon has somewhat shifted its focus to Amrix and...

Business Week:  Jun 20 2008 4:27PM
Matching: fentora
Find similar documents
HTML
100%
Analysts see higher drug sales for Cephalon
Cephalon has somewhat shifted its focus to Amrix and Treanda following a negative recommendation from a Food and Drug Administration panel on the pain tablet Fentora.

The drug is approved to treat severe pain flare-ups in cancer...

Yahoo! Canada:  Jun 20 2008 4:26PM
Matching: fentora
Find similar documents
HTML
100%
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
Introduction The neuropathic pain market is forecast to almost triple to over $6.3 billion by the end of the forecast period in 2017.

The growth in the market is spurred on by the uptake of Pfizer's Lyrica (pregabalin), forecast to reach...

Datamonitor:  Jun 18 2008 11:23PM
Matching: fentora
Find similar documents
HTML
100%
Pipeline and Commercial Insight: Neuropathic Pain- UCB's Vimpat set to compete with major players
Introduction The neuropathic pain market is forecast to almost triple to over $6.3 billion by the end of the forecast period in 2017.

The growth in the market is spurred on by the uptake of Pfizer's Lyrica (pregabalin), forecast to reach...

Datamonitor:  Jun 16 2008 10:55PM
Matching: fentora
Find similar documents
HTML
100%
Cephalon Moves Ahead With Its RFID E-pedigree Plans
International biopharmaceutical company Cephalon will enter a new phase in deploying RFID technology in its supply chain by affixing passive UHF RFID tags to cardboard shipping containers and serializing the EPC numbers on those tags that...
RFID Journal:  Jun 15 2008 2:44AM
Matching: fentora
Find similar documents
HTML
100%
Pipeline and Commercial Insight: Neuropathic Pain
Introduction The neuropathic pain market is forecast to almost triple to over $6.3 billion by the end of the forecast period in 2017.

The growth in the market is spurred on by the uptake of Pfizer's Lyrica (pregabalin), forecast to reach...

Datamonitor:  Jun 13 2008 1:36AM
Matching: fentora
Find similar documents
HTML
100%
Cephalon sues Watson over Fentora patent
_ Cephalon sues Watson over Fentora patent.
Drug Store News:  Jun 12 2008 3:12AM
Matching: fentora
Find similar documents
HTML
100%
Cephalon Sues to Block Generic Fentora
Check out our free and informative ezines and sign up now Sign Up Cephalon has filed a patent infringement suit to prevent the FDAs approval of Watsons generic version of its pain drug Fentora.

Watson submitted its ANDA with a...

FDA News:  Jun 10 2008 10:48PM
Matching: fentora
Find similar documents
HTML
100%
Cephalon Heads to Court to Stop Watson’s Generic Fentora
Check out our free and informative ezines and sign up now This article is viewab Cephalon Heads to Court to Stop Watson’s Generic Fentora.
FDA News:  Jun 11 2008 3:22PM
Matching: fentora
Find similar documents
HTML
100%
Cephalon files patent infringement lawsuit against Watson
Cephalon, Inc.

announced that it and its wholly-owned subsidiary CIMA LABS INC.

have filed a lawsuit in US District Court in Delaware against Watson Pharmaceuticals, Inc.

and its wholly-owned subsidiary, Watson Laboratories, Inc., for...

PharmaBiz:  Jun 7 2008 8:38AM
Matching: fentora
Find similar documents
HTML
100%
Cephalon files patent infringement lawsuit against Watson Pharmaceuticals
The US patents do not expire until 2019.

The lawsuit is based upon an abbreviated new drug application (ANDA) filed by Watson seeking FDA approval for a generic equivalent of fentanyl buccal tablets to be sold in the US.

Watson alleges...

Pharmaceutical Business Review:  Jun 5 2008 4:16AM
Matching: fentora
Find similar documents
HTML
100%
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for Fentora
/PRNewswire-FirstCall/ -- Cephalon, Inc.

announced today that a Joint Advisory Committee to the U.S.

Food and Drug Administration (FDA) voted not to recommend approval of an expanded label for FENTORA(R) (fentanyl buccal tablet) [C-II]...

Pharma Live:  May 7 2008 3:41PM
Matching: fentora
Find similar documents
HTML
100%
UPDATE 2-Wider use of Cephalon drug too risky-US advisers
(Reuters) - U.S.

health officials should reject expanded use of Cephalon Inc's (CEPH.O: Quote, Profile, Research) Fentora pain drug beyond cancer patients because of the potential for abuse of the powerful narcotic, an advisory panel...

Reuters:  May 7 2008 12:30AM
Matching: fentora
Find similar documents
HTML
100%
Cephalon: 'Not Surprised' by FDA Panel Vote
A Food and Drug Administration advisory panel voted 17-to-3 Tuesday to recommend the regulatory agency not grant wider approval for Cephalon's CEPH The drug is currently approved to treat breakthrough pain, or severe pain in cancer patients...
TheStreet.com:  May 6 2008 11:09PM
Matching: fentora
Find similar documents
HTML
100%
FDA panel rejects expanded use for Fentora
A Food and Drug Administration advisory panel voted 17-to-3 Tuesday against recommending an expanded marketing label for Fentora, a pain medicine marketed by Cephalon Inc.

The FDA generally follows the recommendations of its advisory...

Philadelphia Business Journal:  May 7 2008 11:35AM
Matching: fentora
Find similar documents
HTML
100%
On the Watch: Cisco and Disney report quarterly results
NEW YORK (AP) - Shares of Cisco Systems Inc.

may see heavy trading Wednesday after the networking equipment maker posted a larger-than-expected profit in its fiscal third quarter.

Cisco's profit fell 5 percent for the quarter, but its...

Sharewatch:  May 6 2008 11:02PM
Matching: fentora
Find similar documents
HTML
100%
Cephalon: FDA panel votes against approval of expanded label for Fentora
SAN FRANCISCO (Thomson Financial) - Cephalon Inc.

late Tuesday said a joint advisory committee to the Food and Drug Administration voted not to recommend approval of an expanded label for Fentora for the management of breakthrough...

Sharewatch:  May 6 2008 10:27PM
Matching: fentora
Find similar documents
HTML
100%
U.S. FDA concerned over wider Cephalon pain drug use
WASHINGTON (Reuters) - Allowing Cephalon Inc to market its Fentora pain drug more widely for patients without cancer could have 'devastating effects,' a U.S.

Food and Drug Administration official said in documents released on Friday....

Reuters Health:  May 3 2008 12:20AM
Matching: fentora
Find similar documents
HTML
100%
Watson files ANDA for generic Fentora
Watson Pharmaceuticals, Inc, a leading specialty pharmaceutical company, said its subsidiary Watson Laboratories, Inc.

has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to...

PharmaBiz:  May 3 2008 8:35AM
Matching: fentora
Find similar documents
HTML
100%
FDA discouraging expanded use of Cephalon painkiller
A Food and Drug Administration official said in documents released today that allowing Cephalon Inc.

to sell its Fentora pain drug more widely for patients without cancer could lead to potentially fatal abuse.Fentora, a potent...

Philadelphia Inquirer:  May 2 2008 5:33PM
Matching: fentora
Find similar documents
HTML
100%
U.S. FDA concerned over wider Cephalon pain drug use
WASHINGTON Approving Cephalon Inc's Fentora pain drug for patients without cancer could have devastating effects, a Food and Drug Administration official said in documents released Friday.

The company is seeking wider U.S.

approval...

SignOn San Diego:  May 2 2008 6:29PM
Matching: fentora
Find similar documents
HTML
100%
UPDATE 1-US FDA concerned over wider Cephalon pain drug use
(Reuters) - Approving Cephalon Inc's (CEPH.O: Quote, Profile, Research) Fentora pain drug for patients without cancer could have 'devastating effects,' a U.S.

Food and Drug Administration official said in documents released on Friday...

Reuters:  May 2 2008 2:28PM
Matching: fentora
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.